1-6 of 6
Mohamad A. Hussein, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Increased Incidence of Therapy Related Myeloid Neoplasia (t-MN) After Initial Therapy for CLL with Fludarabine-Cyclophosphamide (FC) Vs Fludarabine (F): Long-Term Follow-up of US Intergroup Study E2997

Mitchell R Smith, MD, PhD, Donna Neuberg, ScD, Ian W. Flinn, MD, PhD, Michael R. Grever, M.D., John M. Bennett, MD, Gordon Dewald, Elisabeth M Paietta, PhD, Mark R. Litzow, MD, Jacob M. Rowe, David Lucas, PhD, Shinichi Kitada, Ph.D., Diane F. Jelinek, PhD, John G. Gribben, MD, DSc, John C. Byrd, MD, John C. Reed, MD, PhD, Mohamad A. Hussein, M.D., Frederick R. Appelbaum, MD, Richard A. Larson, MD, Dennis F Moore, Jr, MD, Martin S. Tallman, MD
Journal: Blood
Blood (2010) 116 (21): 924.
https://doi.org/10.1182/blood.V116.21.924.924
Published: 2010
Journal Articles

Results of a Phase I Study of GRN163L, a Direct Inhibitor of Telomerase, in Patients with Relapsed and Refractory Multiple Myeloma (MM)

Asher Alban Chanan-Khan, MD, Nikhil C. Munshi, MD, Mohamad A. Hussein, M.D., Laurence Elias, MD, Fabio Benedetti, M.D., Jennifer Smith, Ph.D., Soo-Peang Khor, Ph.D., Carol A. Huff, MD
Journal: Blood
Blood (2008) 112 (11): 3688.
https://doi.org/10.1182/blood.V112.11.3688.3688
Published: 2008
Journal Articles

Superiority of Lenalidomide (Len) Plus High-Dose Dexamethasone (HD) Compared to HD Alone as Treatment of Newly-Diagnosed Multiple Myeloma (NDMM): Results of the Randomized, Double-Blinded, Placebo-Controlled SWOG Trial S0232.

Jeffrey A. Zonder, MD, John Crowley, Ph.D., Mohamad A. Hussein, M.D., Vanessa Bolejack, Ph.D, Dennis F. Moore, Sr.M.D., Brock F. Whittenberger, M.D., Muneer H. Abidi, M.D., Brian G.M. Durie, M.D., Bart Barlogie, M.D.
Journal: Blood
Blood (2007) 110 (11): 77.
https://doi.org/10.1182/blood.V110.11.77.77
Published: 2007
Journal Articles

Phase-1 Study of ZIO-101: A New Organic Arsenic Active in Acute Myelogenous Leukemia (AML) and Multiple Myeloma (MM).

James R. Berenson, MD, Ralph Vincent V. Boccia, M.D., Mohamad A. Hussein, M.D., Andrew Belch, M.D., Lawrence Boise, M.D., Brian Schwartz, M.D., Robert Peter Gale, M.D.,Ph.D., Steven M. Kornblau, M.D.
Journal: Blood
Blood (2006) 108 (11): 1966.
https://doi.org/10.1182/blood.V108.11.1966.1966
Published: 2006
Journal Articles

Erythropoietic Agents and Venous Thromboembolic Events in Multiple Myeloma Patients Treated with Anthracycline Based Chemotherapy and Immunomodulators.

Rachid Baz, MD, Steven M. Fruchtman, M.D., Jerome B. Zeldis, M.D., Esteban Walker, Ph.D, Mohamad A. Hussein, M.D.
Journal: Blood
Blood (2006) 108 (11): 5119.
https://doi.org/10.1182/blood.V108.11.5119.5119
Published: 2006
Journal Articles

Aspirin Decreases the Thrombotic Complications (DVT) of Liposomal Doxorubicin, Vincristine, Decreased Frequency Dexamethasone and Thalidomide (DVd-T) Treatment of Multiple Myeloma (MM).

Rachid Baz, M.D., Kandice Marchant, M.D., Erin O. Yiannaki, M.S., Luba Platt, Catherine Brand, Elisa Tso, M.D., Mohamad A. Hussein, M.D.
Journal: Blood
Blood (2004) 104 (11): 2397.
https://doi.org/10.1182/blood.V104.11.2397.2397
Published: 2004